APTIMA Trichomonas vaginalis Assay

The Aptima Trichomonas vaginalis (ATV) assay uses nucleic acid amplification to test for T. vaginalis in clinician-collected endocervical swabs, clinician-collected vaginal swabs, female urine specimens, and specimens collected in PreservCyt Solution from symptomatic or asymptomatic women. The ATV assay is currently available for use on the Panther and Tigris automated test platforms.T. vaginalis is a sexually transmitted parasite that can cause vaginitis, urethritis, premature membrane rupture in pregnancy, and makes women more susceptible to infection with HIV-1. The World Health Organization estimates there are 180 million new cases of Trichomonas infection annually worldwide, making the infection more prevalent than chlamydia and gonorrhea.

The Aptima Trichomonas vaginalis assay is an in vitro qualitative nucleic acid amplification test (NAAT) for the detection of ribosomal RNA (rRNA) from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Panther System and Tigris DTS System. The assay utilizes the same technology as the Aptima Combo 2 assay.

DescriptionQuantityCatalog
APTIMA Trichomonas vaginalis Assay, TIGRIS 100 tests
250 tests

303065
302806

APTIMA Trichomonas vaginalis Assay, PANTHER 100 tests
250 tests 

303536
303537 

APTIMA Trichomonas vaginalis Controls Kit  

302807

Cat #ProductKit SizePI
303065  APTIMA Trichomonas vaginalis Assay TIGRIS 100 tests PI
302806 APTIMA Trichomonas vaginalis Assay TIGRIS 250 tests PI
303536 APTIMA Trichomonas vaginalis Assay PANTHER 100 tests PI
303537 APTIMA Trichomonas vaginalis Assay PANTHER 250 tests PI
302807 APTIMA Trichomonas vaginalis Controls Kit - PI

To access current MSDS documents for this product, please go to the MSDS tab above, or 
click here and select the specific product information you need.

The APTIMA Trichomonas vaginalis assay is FDA-cleared for IVD use.

Performance Data

Performance Data for APTIMA Trichomonas vaginalis Assay